Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengtai Biological is a biotechnology company based in Beijing, China, specializing in the development and production of recombinant proteins and monoclonal antibodies. The company operates as a comprehensive service provider, offering contract research (CRO) and contract manufacturing (CMO) services to the global life sciences industry. Their core expertise lies in high-efficiency protein expression systems and large-scale cell culture technologies. Hengtai Biological's product portfolio includes a wide range of cytokines, growth factors, and diagnostic reagents used in both research and clinical applications. By leveraging its advanced technology platforms, the company aims to accelerate the drug discovery process and provide high-quality biological materials for therapeutic development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengtai Bio.